The identification and validation of biomarkers offers invaluable insights into the early detection, prognosis, and therapeutic monitoring of cancer and autoimmune diseases. The integration of multi-omics technologies—genomics, transcriptomics, proteomics, and metabolomics—has accelerated the discovery of these novel biomarkers. However, translating these discoveries into clinical practice rem...
"Breaking New Ground: Clinical and Translational Research on Modern Epidemics of Cancer and Diabetes" will investigate the pioneering advancements in understanding and combating two of the most critical diseases of the 21st century. This issue will explore the latest clinical and translational research aiming at understanding the interplay between cancer and diabetes.
The significance of the topi...